Laurus Labs (Abbreviated New Drug Application) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Asset Purch.
  • Financing Rounds
  • 1

Laurus Labs (Abbreviated New Drug Application) General Information

Description

An FDA-approved abbreviated new drug application (ANDA), tenofovir disoproxil fumarate (TDF), is indicated for the treatment of hepatitis B virus (HBV).

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Other Business Products and Services
Drug Discovery
Other Healthcare
Primary Office
  • Serene Chambers
  • Road Number 7, Banjarahills
  • Hyderabad, Telangana 500034
  • India
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Laurus Labs (Abbreviated New Drug Application) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Laurus Labs (Abbreviated New Drug Application)‘s full profile, request access.

Request a free trial

Laurus Labs (Abbreviated New Drug Application) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Laurus Labs (Abbreviated New Drug Application)‘s full profile, request access.

Request a free trial